ArticleFood science & nutrition2025
Comparative Study of Hypoglycemic Effects and Mechanisms of Crude and Wine-Processed Polysaccharides From
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polygonatum sibiricum (PS), a traditional food and medicinal plant, primarily consists of PS polysaccharides (PSP), which have been documented to possess hypoglycemic properties. Despite the fact that wine-processed PSP (PSPW) represents the predominant form utilized in clinical applications of PS, research has predominantly concentrated on its crude PSC (PSPC). The exact pathways responsible for the hypoglycemic effects of PSPW need further elucidation. To evaluate the hypoglycemic effects and related mechanisms of PSPC and PSPW, we applied PSPC and PSPW to an oxidative stress injury model using HepG2 cells and a T2DM rat model induced by streptozotocin (STZ). Data showed that both PSPC and PSPW can decrease the glucose oxidase (GOD) activity and reduce ROS levels in the oxidative stress injury model of HepG2 cells. Furthermore, PSPC and PSPW can not only ameliorate liver and kidney damage in T2DM rats, but also significantly improve symptoms such as FBG and weight loss. They can also reduce the activities of TG, TC, and GSP in serum, increase the activities of NEFA and INS, and upregulate the mRNA expression levels of PI3K, AKT, INSR, and GLUT-2 in liver tissue, as well as the protein expression levels of P-AKT, PI3K, p-IRS1, and GLUT-2. Moreover, the PSPW group shows a more significant improvement effect than the PSPC group. Overall, our study demonstrates that PSPC and PSPW exert their hypoglycemic effects by regulating oxidative stress and the insulin signaling pathway. Our observations aim to offer novel perspectives on PSPW's potential utilization as a therapeutic candidate and functional food components.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.